Unigef 250mg Tablet 10s is prescribed for cancer treatment It targets epidermal growth factor receptor EGFR in both normal and cancer cells disrupting signals necessary for cancer cell growth Gefitinib falls under cancer medications and inhibits cancer cell growth It targets the EGFR present in healthy and cancerous cells interrupting communication pathways crucial for cancer cell growth and survival Follow the prescribed dose and duration as directed by your doctor Common side effects may include diarrhea dry skin loss of appetite nausea rash stomatitis vomiting weakness and weight loss It is associated with an increased risk of interstitial lung disease Prompt medical attention is necessary for symptoms such as cough difficulty breathing and fever If a dose is missed take it when remembered Avoid doubling doses Consult your doctor for guidance on managing missed doses
